Sign in

Trial result ·

Using cognitive behavioral therapy-based chatbots to alleviate symptoms of insomnia, depression, and anxiety: A randomized controlled trial.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This trial tested a chat program for people with insomnia. The program was based on a sleep therapy called CBT-I. The team took 80 patients from a mind and body clinic in Taiwan. Chance decided which group each person joined. One group used the chatbot for 4 weeks. The other group read basic sleep tips on a website. In the end, 35 and 31 people finished all steps.

What they found

The team used forms to rate sleep quality and mental health. People who used the chatbot slept better on these forms. Their scores on the mental health forms also went down. The team says these changes were unlikely to be due to chance. People in the website group showed no clear change.

What it means for patients

The authors say the chatbot helped both sleep and mental health. They see it as an easy way to get sleep training. They note that face-to-face therapy needs many resources. The authors think the chatbot could have wide use in clinics.

Why it is not certain yet

Some people dropped out or did not finish all the tests. The chatbot was used for just 4 weeks. The abstract gives no results from after the 4 weeks ended. All people came from one clinic in Taiwan. The abstract does not compare the groups head to head.

The registered trial

The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.

Source

Using cognitive behavioral therapy-based chatbots to alleviate symptoms of insomnia, depression, and anxiety: A randomized controlled trial.

PubMed · PMID 41296540

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Insomnia publications
Using cognitive behavioral therapy-based chatbots to alleviate symptoms of insomnia, depression, and anxiety: A randomized controlled trial. · Insomnia news explained – Frontlight Research